Cutaneous lymphoma and ultraviolet radiation

Ultraviolet Radiation and Cutaneous Lymphoma

Sample size: 827 publication

Author Information

Author(s): Hershel Zackheim

Primary Institution: University of California at San Francisco

Hypothesis

The immunosuppressive effect of ultraviolet radiation may contribute to the development of cutaneous lymphoma.

Conclusion

The study highlights the effectiveness of UV-B in treating early stage cutaneous T-cell lymphoma, particularly mycosis fungoides.

Supporting Evidence

  • UV-B is well documented as effective in treating early stage cutaneous T-cell lymphoma.
  • The incidence of cutaneous lymphoma in the EORTC registry was four times more frequent for CTCL than for cutaneous B-cell lymphoma.
  • Approximately 5-6% of registered patients at the University of California clinic had non-MF type cutaneous lymphoma.

Takeaway

Ultraviolet light can help treat a type of skin cancer called cutaneous T-cell lymphoma, especially in its early stages.

Limitations

The comparison of data from different studies requires careful qualification due to differences in definitions and populations.

Participant Demographics

The study involved patients with cutaneous lymphoma, including both mycosis fungoides and non-mycotic types.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication